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Losses of bone tissues occur due to several 
factors, most importantly due to accidents. The 
bone tissue has an uncommon capacity to 
regenerate with the complete substitution of the 
harmed tissue by de novo formed tissue. 
However, there is a physiological limit in which 
the organism is capable to accomplish the task of 
self-reconstruction without surgical intervention. 
When the bone loss is larger than this critical 
limit, a surgical intervention is necessary in order 
to achieve tissue reparation. With the 
development of internal rigid fixation systems 
(use of metallic reconstruction plates and 
screws), the opened fracture reductions reached a 
satisfactory level. Nevertheless, the results 
achieved with the use of these techniques are still 
uncertain in cases of large tissue destruction in 
which the losses do not allow a correct 
juxtaposition of the bone fragments. In order to 
try to solve these limitations, surgeons have been 
searching and testing several types of therapeutic 
approaches to obtain aesthetic and functional 
restorations of the harmed anatomical area. 
Among the alternatives, the most used are 
autografts (bone transferred from one site to 
another in the same individual), alografts (bone 
transferred from one individual to another), 
xenografts (bone transferred from one specie to 
another) and aloplastics (synthetic materials). 
Although the autografts are successfully used, 
they have some disadvantages, such as the 
limited amount of bone tissue that can be 
obtained and necessity of a surgery in the donor 
area. Consequently, there is considerable interest 
in developing novel alternatives to de novo 
regenerate bone tissue. With the increase of the 
knowledge of the genetic osteogenic factors and 
genetic engineering, genetic therapy is becoming 
a viable alternative to obtain a satisfactory result 
in bone regeneration. 
 
The in vivo repair of bone tissue is controlled by 
the temporary expression of growth factors genes 
(Bolander, 1992; Sandberg et al., 1993; Linkhart 
et al., 1996; Bostrom et al., 1998), trigged by the 
presence bone morphogenetic proteins (BMPs). 
BMP can be produced in animal cells in culture 
or in transgenic animals. Transfected bovine 
fibroblasts lines can be used as a source of donor 
nucleus to generate transgenic animals through 
nuclear transfer into enucleated bovine oocyte. 
These transgenic animals can further produce 
proteins with pharmaceutical relevance 
(Houdebine, 2000). 
 
It was isolated the human bone morphogenetic 
proteins cDNAs (BMP-2 and BMP-4) that were 
positioned under control of a mammalian 
constitutive promoter. The vectors were used to 
transfect bovine fibroblasts and express the 
BMP-2 and BMP-4 genes. 
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Total RNAs were isolated from bone tissue 
collected from patients with facial trauma (jaw 
fractures between the 7th and 10th day pos-
trauma). All samples were harvested to get the 
best fracture reduction. All surgical procedures 
were carried out in the Unidade de Cirurgia e 
Traumatologia Buco-Maxilo-Facial, Hospital de 
Base de Brasília in accordance with the ethical 
standards of the institutional committee and the 
Helsinki Declaration. 
 
RNA was isolated using Trizol1 and the cDNA 
synthesis was conducted with the Superscript II 
kit1 according to the manufacturer’s instructions. 
 
The BMP genes were amplified by PCR using 
the primer pairs BMP2forw 
(gtgcttcttagacggactgc) / BMP2rev 
(gtactagcgacacccacaac) to amplify the 1,233 bp 
BMP-2 gene, and BMP4forw 
(agccattccgtagtgccatc) / BMP4rev 
(aaggactgcctgatctcagc) to amplify the 1,373bp 
BMP-4 gene. Each PCR reaction was carried out 
in a 25µl mixture containing 60mM Tris-SO4 
(pH 8.9), 18mM ammonium sulfate, 2mM 
MgSO4, 200µM of each dNTP, 200nM of each 
primer, 1U of Taq Platinum high fidelity 
polymerase1. The mixture was overlaid with 
mineral oil, denatured for 2min at 94oC in a MJ 
Research thermal cycler2 and amplified for 30 
cycles (94oC for 15s, 55oC for 30s, 68oC for 
2min). The products were run on a 1% agarose 
gel, stained with ethidium bromide and 
visualized with UV light. The amplified DNA 
sequences were cloned into the pGEM-T easy 
vector3 and sequenced. The genes were then 
cloned in the NotI restriction site from the 
pCMV-β vetor, replacing the β-galactosidase 
gene4, under control of the cytomegalovirus 
(CMV) promoter for expression in mammalian 
cells to generate the vectors pCMV-BMP2 and 
pCMV-BMP4.  
 
Bovine fibroblasts were transfected with the 
vectors pCMV-BMP2 and pCMV-BMP4 using 
the LipofectAmine Plus1 according to the 
manufacturer’s instructions. In order to detect 
BMP-2 and BMP-4 genes expression (mRNA) in 
the transgenic fibroblasts cells, RT-PCR was 
                                                 
1 Invitrogen, Carlsbad, CA, USA. 
2 Waltham, MA, USA. 
3 Promega, Madison, WI, USA. 
4 Clontec, Palo Alto, CA, USA. 
carried out. Total RNA isolation and PCR were 
conducted as previously described. Fig. 1 shows 
the RT-PCR amplification of the 1,233 bp (BMP-
2) and 1,373 bp (BMP-4) DNA sequences in 3 
independent fibroblasts lines. RT-PCR with total 
RNA without cDNA synthesis revealed no 
amplification attesting no contaminations with 
DNA (Fig. 1, lane 6). RT-PCR analyses with 
non-transfected fibroblasts lines (negative 
control) revealed no DNA amplification (Fig. 1, 
lane 5). Western blot analysis, carried out as 
described (Ramoshebi et al., 1999; Viñals et al., 
2002) using polyclonal antibodies5 revealed that 
both BMP-2 and BMP-4 protein is produced in 
the transfected fibroblasts (Fig. 2). 
 
 
Figure 1. RT-PCR analysis of bovine fibroblasts 
cells transfected with the vector pCMV-BMP2 
(A) and pCMV-BMP4 (B). Lane 1: 1 kb Ladder 
(Invitrogen); lanes 2-4: transfected fibroblasts 
cell lines; lane 5: non-transfected fibroblasts 
lines (negative control); lane 6: total RNA 
without cDNA synthesis. 
 
 
Figure 2. Western blot analysis showing the 
presence of BMP-2 (A) and BMP-4 (B) protein 
in transfected bovine fibroblasts. Lanes 1 and 2 
(A and B): transfected fibroblasts; lane 3 (A and 
B): non-transfected fibroblast line. 
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In this report it was able to express human BMP-
2 and BMP-4 genes in bovine transgenic 
fibroblasts. It suggested that the BMPs could be 
produced in cell in culture. In addition, the BMP 
genes can be introduced and expressed in vivo 
(Rech et al., 1996), in order to trigger the de 
novo osteogenesis process. 
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cDNAs dos genes bone morphogenetic protein-2 (BMP-2) e bone morphogenetic protein-4 (BMP-4) 
foram sintetizados a partir de RNA total extraído de tecidos ósseos de pacientes que apresentavam 
trauma facial (fraturas do maxilar entre o 7º e o 10º dia pós-trauma) e clonados num vetor para 
expressão em células mamíferas, sob controle do promotor de citomegalovírus (CMV). Os vetores 
contendo os genes BMP-2 e o BMP-4 foram utilizados para a transfecção de fibroblastos bovinos. 
mRNAs foram indiretamente detectados por RT-PCR nas células transfectadas. As proteínas BMP-2 e 
BMP-4 foram detectadas mediante análises de Western blot. Os resultados demonstram a possibilidade 
de produção desses fatores de crescimento celular em fibroblastos bovinos. Essas células poderão ser 
utilizadas como fontes doadoras de material genético para a técnica de transferência nuclear na geração 
de animais transgênicos. 
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